A feasibility study to evaluate the efficacy and safety of endoscopic ultrasound-guided through-the-needle pancreatic cyst wall biopsy

A feasibility study to evaluate the efficacy and safety of endoscopic ultrasound-guided through-the-needle pancreatic cyst wall biopsy - A feasibility study of EUS-TNPCB

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016311

Enrollment

Registered

2015-01-26

Start date

2015-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cystic neoplasm

Interventions

EUS-guided through-the-needle pancreatic cyst wall biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic cystic neoplasms

Exclusion criteria

Exclusion criteria: 1, Performance status 2 or more 2, ASA classification 3 or more 3, Coagulopathy 4, Contraindication for upper endoscopy

Design outcomes

Primary

Measure	Time frame
An adequacy rate of tissue sampling	—

Secondary

Measure	Time frame
Histopathological diagnosis A rate of adverse event	—

Countries

Japan

Contacts

Public ContactKazumichi Kawakubo

Hokkaido University Graduate School of Medicine Department of Gastroenterology and Hepatology

kkawakubo-gi@umin.ac.jp011-706-7715

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026